Biotech company Harness Therapeutics has appointed experienced biopharma executive Meenu Chhabra Karson as chair of its board of directors. The Babraham Research Campus-based company, which is focused on protein upregulation to develop next generation therapeutics for neurodegenerative diseases, said Ms Chhabra Karson brings business, scientific and operational expertise as Harness eyes its next phase of growth. Harness Therapeutics is advancing an oligonucleotide-based platform for controlled upregulation of central nervous system targets, with a lead programme in Huntington’s disease. Ms Chh…